Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02PGM
|
|||
| Former ID |
DNC002217
|
|||
| Drug Name |
ISIS 16124
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Company |
Isis Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | E2A-Pbx1 messenger RNA (E2A-Pbx1 mRNA) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | US patent application no. 6,607,915, Antisense inhibition of E2A-Pbx1 expression. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.